Please assess the completion status of the following clinical trial:

Trial Title: Study to Assess the Effectiveness and Safety of FLECTOR Patch for Treatment of Acute Back Strain

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Participants in the study must:~1. have acute, non-radicular back strain with onset up to 10 days before the first visit~2. have intact, non-damaged skin at the proposed patch application site~3. be untreated or unresponsive to conservative pain treatment regimens and/or opioids~4. have a minimum pain intensity score of four (4) or more on a scale of 1-10 (a rating of zero (0) being no pain and a rating of ten (10) being pain as bad as you can imagine)~5. have a normal neurologic examination~Exclusion Criteria:~Participants may not be in the study if they:~1. have had surgery or other chronic pain condition within 3 months before first treatment~2. have back pain radiating below the knee at time of enrollment~3. have neuropathic pain or have been treated with gabapentin or pregabalin for neuropathy~4. are being treated for or are known to currently have kidney or liver disease~5. have certain other diseases or are using certain types of other drugs.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- FLECTORA Patch (diclofenac epolamine topical patch) 1.3% (Type: EXPERIMENTAL): One patch applied every 12 hours

Based on this trial design, predict the completion outcome and termination type (if applicable).